<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00317655</url>
  </required_header>
  <id_info>
    <org_study_id>Jointcare/Fe/1/DK</org_study_id>
    <secondary_id>Eudractnr. 2005-002691-15</secondary_id>
    <nct_id>NCT00317655</nct_id>
  </id_info>
  <brief_title>Glucosamine Sulphate, Ginger, Ginger-Avocado-Soya and Ginger-Ibuprofen for Chronic Back Pain</brief_title>
  <official_title>Glucosamine Sulphate, Ginger, Ginger-Avocado-Soya and Ginger-Ibuprofen for Chronic Back Pain - a Randomized, Double Blind, Placebo-Controlled Clinical Investigation With Parallel Groups for 3 Months to Enlighten Joint Health</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ferrosan AS</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ferrosan AS</source>
  <brief_summary>
    <textblock>
      The main purpose of this study is to investigate the ability of some dietary supplement
      products to affect general joint health and life quality in a selected population with back
      pain.

      The study is randomized and double - blind, with parallel groups receiving treatment for a
      duration of 12 weeks.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2006</start_date>
  <completion_date type="Actual">April 2007</completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>mm pain relief (visual analog scale [VAS]) during past 24 hours compared from start (0 weeks) and 12 weeks</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percentage of responders showing more than 15 mm improvement in pain relief</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>mm pain relief (VAS) within past 7 days at weeks 1, 2, 4, 6, 9, and 12</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Function level according to Roland Morris-questionnaire (23 points)</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patients' Global Impression of Change (pain)</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patients' satisfaction with pain medication</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Use of rescue medication</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse events profile</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body weight (start and 12 weeks)</measure>
  </secondary_outcome>
  <enrollment type="Actual">175</enrollment>
  <condition>Back Pain</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Glucosamine sulphate</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ginger</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ginger-Avocado-Soya</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ginger-ibuprofen</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Chronic back pain daily or almost daily for at least 3 months prior to inclusion

          -  Patient classified as I or II according to Quebec Task Force

          -  No intake of glucosamine sulphate, ginger, or avocado-soya extract during last 3
             months

          -  Fertile women should, at start, have a negative pregnancy test and during test use
             acceptable prevention methods (p-pills, intrauterine device [IUD], depot gestagen,
             subdermal implant, hormonal vaginal ring or transdermal depot plaster).

          -  Anxiolytics, muscle relaxants, physiotherapy, chiropractic treatment, or training
             should not have been used during last 3 months.

        Exclusion Criteria:

          -  Serious disease (eg. heart disease, cancer (within past 5 years), kidney disease,
             blood diseases, inflammatory diseases (eg. chronic rheumatoid arthritis, fibromyalgia)

          -  Suspicion that back pain is caused by osteoporosis, other arthritic condition than
             osteoarthritis, cancer, infection, pain from organ disease or psychosomatic cancer
             disease.

          -  Uncontrolled elevated blood pressure, defined as systolic ≥ 160 mm Hg or diastolic ≥
             90 mm Hg.

          -  VAS measurement at inclusion less than ved 30 mm or over 90 mm.

          -  Prehistory of ulcer, stomach surgery, or inflammatory bowel disease

          -  Pain relief medication besides must not be taken during study.

          -  Patients in need of non-steroidal anti-inflammatory drugs (NSAIDs), morphine, or
             similar medication are not eligible. Same is also valid for patients in need of
             injections or acupuncture.

          -  Back surgery within 6 months before inclusion or earlier surgery without effect

          -  &quot;Heart&quot; aspirin (low dose), ulcer medication, or blood thinning medication

          -  Alcohol abuse

          -  Depression

          -  Pregnancy or breastfeeding

          -  Allergy to crustaceans or known intolerance for glucosamine sulphate, ginger, avocado,
             soy, or ibuprofen

          -  Allergy or asthma released by salicylic acid or other arthritis medication (NSAIDs)

          -  Patient who is seeking pension due to back pain or has other economical interests
             connected to his/her back pain
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Keld Østergaard, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Slidgigtinstituttet A/S</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Slidgigtinstituttet A/S</name>
      <address>
        <city>Ishoj</city>
        <zip>2635</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>May 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 23, 2006</study_first_submitted>
  <study_first_submitted_qc>April 23, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 25, 2006</study_first_posted>
  <last_update_submitted>May 16, 2007</last_update_submitted>
  <last_update_submitted_qc>May 16, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 17, 2007</last_update_posted>
  <keyword>back pain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Back Pain</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ibuprofen</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

